Physician

Thomas Edward Lafferty, M.D.

According to 2025 Medicare claims, Thomas Lafferty, M.D. (NPI: 1932191541) practices rheumatology in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is SIMEDHEALTH LLC (NPI: 1639680127; TIN: 823017080) and primary practice location at 34474-3357. Lafferty is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Lafferty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 538 traditional Medicare patients, billed 94,748 HCPCS/CPT codes, and received $834,308 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,942 prescription claims across 658 beneficiaries totaling $3,567,990 in drug costs, led by Enbrel Sureclick (Etanercept). 2015 DME data shows 12 claims. Open Payments data shows 4 records totaling $412. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,180,852 to $3,567,990. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	621	20,930	$477,091
2016	601	20,039	$653,573
2017	610	24,450	$752,968
2018	628	32,986	$926,837
2019	635	48,764	$1,032,954
2020	591	69,355	$1,034,382
2021	555	61,877	$865,952
2022	611	75,265	$940,497
2023	567	72,936	$802,974
2024	538	94,748	$834,308

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	578	4,113	$1,180,852
2016	571	3,793	$1,358,086
2017	584	3,645	$1,645,070
2018	616	3,622	$1,616,012
2019	634	3,648	$1,907,990
2020	646	4,183	$2,350,249
2021	636	3,977	$2,288,699
2022	610	3,623	$3,165,418
2023	629	3,802	$3,765,362
2024	658	3,942	$3,567,990

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$156
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	384	803	$88
96372	Injection of drug or substance under skin or into muscle	226	481	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	255	396	$8
86140	Measurement c-reactive protein for detection of infection or inflammation	251	405	$5
85651	Red blood cell sedimentation rate, to detect inflammation, non-automated	251	406	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	113	4,010	$1,036,596
Humira(Cf)	Adalimumab	69	2,116	$656,936
Humira(Cf) Pen	Adalimumab	44	1,232	$332,435
Enbrel	Etanercept	41	1,148	$306,064
Enbrel Mini	Etanercept	22	616	$163,012

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$412	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas Edward Lafferty, M.D.?

Tedicare shows public-source Medicare data for Thomas Edward Lafferty, M.D. (NPI 1932191541), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Edward Lafferty, M.D. have ACO affiliation data?

Thomas Edward Lafferty, M.D. is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Thomas Edward Lafferty, M.D.?

Thomas Edward Lafferty, M.D. is linked to SIMEDHEALTH LLC (billing NPI 1639680127) in the available physician profile data.

Does Thomas Edward Lafferty, M.D. have Open Payments data?

Thomas Edward Lafferty, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.